These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 22753739

  • 1. Effect of histone deacetylase inhibitors trichostatin A and valproic acid on etoposide-induced apoptosis in leukemia cells.
    Jasek E, Lis GJ, Jasinska M, Jurkowska H, Litwin JA.
    Anticancer Res; 2012 Jul; 32(7):2791-9. PubMed ID: 22753739
    [Abstract] [Full Text] [Related]

  • 2. Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species.
    Rahmani M, Reese E, Dai Y, Bauer C, Payne SG, Dent P, Spiegel S, Grant S.
    Cancer Res; 2005 Mar 15; 65(6):2422-32. PubMed ID: 15781658
    [Abstract] [Full Text] [Related]

  • 3. [Effects of trichostatin A and paclitaxel on apoptosis and mitochondrial membrane potential of human endometrial carcinoma Ark2 cells].
    Yang YN, Wang Y, Wang XG, Jiang SJ.
    Ai Zheng; 2008 Aug 15; 27(8):816-21. PubMed ID: 18710614
    [Abstract] [Full Text] [Related]

  • 4. Histone deacetylase inhibitors induced differentiation and accelerated mineralization of pulp-derived cells.
    Duncan HF, Smith AJ, Fleming GJ, Cooper PR.
    J Endod; 2012 Mar 15; 38(3):339-45. PubMed ID: 22341071
    [Abstract] [Full Text] [Related]

  • 5. Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells.
    Sung ES, Kim A, Park JS, Chung J, Kwon MH, Kim YS.
    Apoptosis; 2010 Oct 15; 15(10):1256-69. PubMed ID: 20582477
    [Abstract] [Full Text] [Related]

  • 6. Combinatorial action of the HDAC inhibitor trichostatin A and etoposide induces caspase-mediated AIF-dependent apoptotic cell death in non-small cell lung carcinoma cells.
    Hajji N, Wallenborg K, Vlachos P, Nyman U, Hermanson O, Joseph B.
    Oncogene; 2008 May 15; 27(22):3134-44. PubMed ID: 18071312
    [Abstract] [Full Text] [Related]

  • 7. Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates.
    Qi H, Ratnam M.
    Cancer Res; 2006 Jun 01; 66(11):5875-82. PubMed ID: 16740727
    [Abstract] [Full Text] [Related]

  • 8. Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.
    Groh T, Hrabeta J, Poljakova J, Eckschlager T, Stiborova M.
    Neuro Endocrinol Lett; 2012 Jun 01; 33 Suppl 3():16-24. PubMed ID: 23353839
    [Abstract] [Full Text] [Related]

  • 9. Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma.
    Poljakova J, Hrebackova J, Dvorakova M, Moserova M, Eckschlager T, Hrabeta J, Göttlicherova M, Kopejtkova B, Frei E, Kizek R, Stiborova M.
    Neuro Endocrinol Lett; 2011 Jun 01; 32 Suppl 1():101-16. PubMed ID: 22167207
    [Abstract] [Full Text] [Related]

  • 10. Synergistic induction of mitochondrial damage and apoptosis in human leukemia cells by flavopiridol and the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA).
    Almenara J, Rosato R, Grant S.
    Leukemia; 2002 Jul 01; 16(7):1331-43. PubMed ID: 12094258
    [Abstract] [Full Text] [Related]

  • 11. The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways.
    Meng J, Zhang HH, Zhou CX, Li C, Zhang F, Mei QB.
    Oncol Rep; 2012 Jul 01; 28(1):384-8. PubMed ID: 22552631
    [Abstract] [Full Text] [Related]

  • 12. Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr/Abl+ human myeloid leukemia cells.
    Yu C, Rahmani M, Almenara J, Subler M, Krystal G, Conrad D, Varticovski L, Dent P, Grant S.
    Cancer Res; 2003 May 01; 63(9):2118-26. PubMed ID: 12727828
    [Abstract] [Full Text] [Related]

  • 13. Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways.
    Shankar S, Singh TR, Fandy TE, Luetrakul T, Ross DD, Srivastava RK.
    Int J Mol Med; 2005 Dec 01; 16(6):1125-38. PubMed ID: 16273296
    [Abstract] [Full Text] [Related]

  • 14. HDAC inhibitors potentiate the apoptotic effect of enzastaurin in lymphoma cells.
    Bodo J, Sedlak J, Maciejewski JP, Almasan A, Hsi ED.
    Apoptosis; 2011 Sep 01; 16(9):914-23. PubMed ID: 21667043
    [Abstract] [Full Text] [Related]

  • 15. Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells.
    Gilardini Montani MS, Granato M, Santoni C, Del Porto P, Merendino N, D'Orazi G, Faggioni A, Cirone M.
    Cell Oncol (Dordr); 2017 Apr 01; 40(2):167-180. PubMed ID: 28160167
    [Abstract] [Full Text] [Related]

  • 16. Abrogation of MAPK and Akt signaling by AEE788 synergistically potentiates histone deacetylase inhibitor-induced apoptosis through reactive oxygen species generation.
    Yu C, Friday BB, Lai JP, McCollum A, Atadja P, Roberts LR, Adjei AA.
    Clin Cancer Res; 2007 Feb 15; 13(4):1140-8. PubMed ID: 17317822
    [Abstract] [Full Text] [Related]

  • 17. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells.
    Sonnemann J, Kumar KS, Heesch S, Müller C, Hartwig C, Maass M, Bader P, Beck JF.
    Int J Oncol; 2006 Mar 15; 28(3):755-66. PubMed ID: 16465382
    [Abstract] [Full Text] [Related]

  • 18. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
    Cheong JW, Chong SY, Kim JY, Eom JI, Jeung HK, Maeng HY, Lee ST, Min YH.
    Clin Cancer Res; 2003 Oct 15; 9(13):5018-27. PubMed ID: 14581377
    [Abstract] [Full Text] [Related]

  • 19. Combinatorial effects of PARP inhibitor PJ34 and histone deacetylase inhibitor vorinostat on leukemia cell lines.
    Jasek E, Gajda M, Lis GJ, Jasińska M, Litwin JA.
    Anticancer Res; 2014 Apr 15; 34(4):1849-56. PubMed ID: 24692719
    [Abstract] [Full Text] [Related]

  • 20. Synergistic killing of human leukemia cells by antioxidants and trichostatin A.
    Kang J, Chen J, Zhang D, Da W, Ou Y.
    Cancer Chemother Pharmacol; 2004 Dec 15; 54(6):537-45. PubMed ID: 15248029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.